BIOLASE, Inc.
BIOL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $5 | $6 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $5 | $6 | $5 |
| Inventory | $10 | $11 | $11 | $11 |
| Other Curr. Assets | $3 | $1 | $2 | $1 |
| Total Curr. Assets | $19 | $22 | $25 | $25 |
| Property Plant & Equip (Net) | $5 | $5 | $6 | $7 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $8 | $9 | $9 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $31 | $34 | $35 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $5 | $6 |
| Short-Term Debt | $18 | $14 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $2 | $2 | $2 |
| Other Curr. Liab. | $7 | $9 | $10 | $8 |
| Total Curr. Liab. | $31 | $31 | $21 | $20 |
| LT Debt | $0 | $0 | $14 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $1 | $3 | $1 | -$2 |
| Total NC Liab. | $2 | $4 | $15 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $32 | $35 | $36 | $35 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $2 | $2 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$328 | -$326 | -$323 | -$317 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $323 | $322 | $320 | $315 |
| Total Equity | -$5 | -$4 | -$2 | -$0 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $31 | $34 | $35 |
| Net Debt | $15 | $9 | $11 | $11 |